Shin-Etsu Chemical Co., Ltd. (OTCMKTS:SHECY - Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $20.16 and traded as low as $19.86. Shin-Etsu Chemical shares last traded at $19.89, with a volume of 265,854 shares trading hands.
Shin-Etsu Chemical Trading Down 1.5 %
The firm has a market capitalization of $79.61 billion, a PE ratio of 23.39 and a beta of 1.21. The firm's fifty day moving average price is $20.74 and its 200 day moving average price is $20.16.
Shin-Etsu Chemical (OTCMKTS:SHECY - Get Free Report) last posted its quarterly earnings results on Friday, July 26th. The basic materials company reported $0.23 EPS for the quarter. The firm had revenue of $3.84 billion during the quarter. Shin-Etsu Chemical had a return on equity of 11.41% and a net margin of 21.14%. On average, analysts predict that Shin-Etsu Chemical Co., Ltd. will post 0.9 earnings per share for the current year.
About Shin-Etsu Chemical
(
Get Free Report)
Shin-Etsu Chemical Co, Ltd. provides infrastructure, electronics, and functional materials in Japan. It is also involved in processing and specialized related services. The company operates through Infrastructure Materials; Electronics Materials; Functional Materials; and Processing and Specialized Services segments.
Further Reading
Before you consider Shin-Etsu Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shin-Etsu Chemical wasn't on the list.
While Shin-Etsu Chemical currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.